Pharma Mar, S.A.
PHMMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.6% | -19.5% | -14.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 95.3% | 93.9% | 93.1% | 92.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | -$0 | $0 | $0 | $0 |
| SG&A Expenses | -$0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | -$0 | $0 | $0 |
| % Margin | 3.7% | -2.4% | 22.4% | 40.2% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $0 | -$0 | $0 | $0 |
| Tax Expense | -$0 | -$0 | -$0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 14.9% | 0.7% | 25.1% | 40.4% |
| EPS | 1.49 | 0.064 | 2.73 | 5.14 |
| % Growth | 2,246.5% | -97.7% | -46.9% | – |
| EPS Diluted | 1.49 | 0.064 | 2.73 | 5.13 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 12.1% | 2.9% | 26.5% | 45.3% |